Current filters:  
Canada
Healthcare
Canada
Smart & Biggar
The PMPRB has extended the deadline for comments on the revised draft Guidelines to August 4, 2020.
Field LLP
On Monday, July 6, 2020, the Government of Alberta tabled Bill 30, the Health Statutes Amendment Act, 2020. This proposed legislation amends a number of existing Acts, including the Alberta Health Professions Act.
Bereskin & Parr LLP
Repurposing existing or abandoned drugs is an attractive route to finding a treatment and cure for COVID-19 quickly. To initiate such efforts, the World Health Organization (WHO) has set up...
Torys LLP
Last week, we provided an overview and analysis of the Federal Court of Canada's review of new amendments to the Patented Medicines Regulations was released.
Osler, Hoskin & Harcourt LLP
As provincial governments in Canada begin to lift their respective emergency measures, keeping track of the different guidelines is a challenge.
Gowling WLG
Quebec is now finalizing the reopening of its economy, which began over the past few weeks. During the June 25, 2020 press conference, Quebec's director of public health,...
Osler, Hoskin & Harcourt LLP
In theory, these licenses allow the Minister to facilitate the manufacture of a safe and effective COVID-19 treatment where issued patents otherwise pose a barrier.
Gluckstein Personal Injury Lawyers
This pandemic has been a unique and unsettling experience for just about everyone. Many issues have arisen that we may not have considered when we first learned about COVID-19.
Blake, Cassels & Graydon LLP
Canada has a vibrant life sciences and pharmaceutical industry, with a broad array of firms conducting research and developing innovative medicines, generic medicines, biosimilar products...
Smart & Biggar
On June 4, 2020 the Federal Court dismissed an application for judicial review brought by Canada RNA Biochemical Inc of Health Canada's refusal of C-RNA's application for a natural health product...
Smart & Biggar
On June 3, 2020, a proposed class action was commenced against over 50 generic drug manufacturers.
Smart & Biggar
Further to our June 1, 2020 update, regulations amending the coming into force date of the Regulations Amending the Patented Medicines Regulations
MLT Aikins LLP
Changes are coming to the Canadian grain system as a result of the Canada-United States-Mexico Agreement ("CUSMA") which is set to come into effect on July 1, 2020. On June 23, 2020, the Canadian Grain Commission announced...
Fasken
Measures implemented over the past two weeks by governments across Canada to respond to the COVID-19 outbreak focus on safely re-opening various businesses and services, including...
Torys LLP
Over the last several years, there has been a great deal of uncertainty regarding Canada's patented drug pricing regime.
Smart & Biggar
Generally, the revised Guidelines add complexity to the price review process for new patented medicines.
Blake, Cassels & Graydon LLP
COVID-19 is transforming the way businesses create products and go-to-market, especially when launching health products during a pandemic, on an expediated timeline.
Smart & Biggar
The PMPRB has just released revised draft Guidelines operationalizing the amended Patented Medicines Regulations, simultaneously beginning a 30-day consultation period.
Norton Rose Fulbright Canada LLP
Amendments to the Patented Medicines Regulations are scheduled to come into force on January 1, 2021.
Norton Rose Fulbright Canada LLP
We previously reported on the Ontario government's efforts to manage the risk of drug shortages in the early days of the pandemic.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Upcoming Events
Tools
Font Size:
Translation
Mondaq Social Media